Prognosis of ovarian cancer in women with type 2 diabetes using metformin and other forms of antidiabetic medication or statins: a retrospective cohort study

BACKGROUND: Ovarian cancer is one of the most lethal cancers and women with type 2 diabetes (T2D) have even poorer survival from it. We assessed the prognosis of ovarian cancer in women with type 2 diabetes treated with metformin, other forms of antidiabetic medication, or statins. METHODS: Study co...

Descripción completa

Detalles Bibliográficos
Autores principales: Urpilainen, Elina, Marttila, Mikko, Hautakoski, Ari, Arffman, Martti, Sund, Reijo, Ilanne-Parikka, Pirjo, Arima, Reetta, Kangaskokko, Jenni, Puistola, Ulla, Hinkula, Marianne, Läärä, Esa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064082/
https://www.ncbi.nlm.nih.gov/pubmed/30055585
http://dx.doi.org/10.1186/s12885-018-4676-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064082/
https://www.ncbi.nlm.nih.gov/pubmed/30055585
http://dx.doi.org/10.1186/s12885-018-4676-z

Ejemplares similares